Espace presse

Qarnot and the Imagine Institute start collaborations to optimize computing power and accelerate research against genetic diseases

18/10/2021

Covid-19: discovery of a molecular signature of pediatric myocarditis

16/09/2021

Launch of the Medtech Generator & Accelerator program developed by Institut du Cerveau, Institut Imagine, Institut Pasteur and Institut de la Vision

10/09/2021

One quarter of severe forms of Covid-19 are explained by a genetic or immunological anomaly

19/08/2021

A new treatment discovered at Institut Imagine and developed by QED Therapeutics enters clinical trial with a first child with achondroplasia in France

09/04/2021

COVID-19: Institut Imagine and Cerba HealthCare are partnering to test for patients likely to develop severe symptoms

18/03/2021

From rare to frequent: the importance of conducting research on genetic diseases

23/02/2021

Autoimmune and inflammatory diseases associated with primary immune deficiencies: 11 major healthcare players in France commit to accelerating the development of precision medicine

14/01/2021

Visit of the President of the Republic to Institut Imagine

04/12/2020

Inauguration of Single-Cell@Imagine

16/10/2020

Nature magazine's TOP 10 for 2020 : 15% of severe forms of Covid-19 are due to genetic and immunological abnormalities.

24/09/2020

Type 1 Interferon Deficiency: A Blood based Signature for Detecting Patients at Risk of Severe Covid-19 for a therapeutic approach

16/07/2020

Partnership research - Imagine launches a website dedicated to industrialists

10/06/2020

World Sickle Cell Day: Hope for treatment with a new gene therapy approach

05/06/2020

COVID-19: several Imagine teams mobilize

19/03/2020